| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.85B | 136.57B | 135.88B | 132.97B | 123.34B | 113.67B |
| Gross Profit | 27.79B | 28.00B | 27.56B | 28.25B | 23.58B | 23.01B |
| EBITDA | 13.62B | 13.52B | 13.72B | 13.00B | 9.54B | 9.76B |
| Net Income | 8.11B | 8.03B | 8.09B | 7.34B | 10.03B | 5.13B |
Balance Sheet | ||||||
| Total Assets | 134.46B | 139.61B | 137.61B | 141.67B | 133.99B | 120.28B |
| Cash, Cash Equivalents and Short-Term Investments | 20.01B | 21.29B | 21.12B | 26.65B | 32.20B | 26.17B |
| Total Debt | 117.00M | 143.00M | 216.00M | 277.00M | 354.00M | 562.00M |
| Total Liabilities | 47.69B | 50.75B | 50.93B | 56.98B | 52.51B | 47.38B |
| Stockholders Equity | 86.39B | 88.46B | 86.25B | 79.67B | 76.97B | 68.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.89B | 218.00M | 2.05B | 3.21B | 3.11B |
| Operating Cash Flow | 0.00 | 13.73B | 7.17B | 8.14B | 4.61B | 6.20B |
| Investing Cash Flow | 0.00 | -5.99B | -7.31B | -5.22B | 3.55B | -2.67B |
| Financing Cash Flow | 0.00 | -8.41B | -5.62B | -8.60B | -2.48B | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥116.77B | 10.07 | ― | 3.72% | 4.93% | 30.22% | |
76 Outperform | ¥77.67B | 6.04 | ― | 3.04% | -0.11% | -31.90% | |
75 Outperform | ¥79.36B | 19.80 | ― | 1.12% | 4.19% | 24.62% | |
74 Outperform | ¥92.86B | 10.97 | ― | 3.02% | 0.51% | 3.23% | |
69 Neutral | ¥555.73B | 23.07 | ― | 3.26% | 15.83% | 124.18% | |
62 Neutral | ¥24.84B | 9.97 | ― | 4.27% | 3.42% | -5.48% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |